Search

everythinglearnresearchcommunity

for

Search:↓

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Betamethasone can effectively treat alopecia areata.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

The document's conclusion cannot be determined as the content is not available.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.